An evaluation of pitavastatin for the treatment of hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An evaluation of pitavastatin for the treatment of hypercholesterolemia

Published:2018-11-27 Issue:1 Volume:20 Page:103-113
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Chan Paul¹,Shao Li²,Tomlinson Brian³⁴^ORCID,Zhang Yuzhen³^ORCID,Liu Zhong-Min⁵

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan.

2. The VIP Department, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

3. Research Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai, China

4. Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong

5. Department of Cardiac Surgery, Shanghai East Hospital, Tongji University, Shanghai, China

Funder

Natural Science Foundation of Shanghai

Fundamental Research Funds for the Central Universities

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1544243

Reference96 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

2. Interpretation of the evidence for the efficacy and safety of statin therapy

3. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

4. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

5. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pitavastatin: A Comprehensive Overview of its Mechanisms, Pharmacokinetics, Pharmacodynamics, and Adverse Effects;2024-02-23

2. Pitavastatin calcium significantly improves glucose and lipid metabolism of patients with coronary atherosclerosis and reduces the occurrence of adverse cardiovascular events;Tropical Journal of Pharmaceutical Research;2024-01-11

3. Position Paper of the Polish Expert Group on the Use of Pitavastatin in the Treatment of Lipid Disorders in Poland Endorsed by the Polish Lipid Association.;Archives of Medical Science;2023-11-26

4. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study;Yonsei Medical Journal;2023

5. Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence;Advances in Experimental Medicine and Biology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3